Discovery of genetic biomarker that could improve the treatment of diabetes.
出版信息
Pharmacogenomics. 2009 Aug;10(8):1217. doi: 10.2217/pgs.09.98.
PMID:19663665
Abstract
摘要
相似文献
1
Discovery of genetic biomarker that could improve the treatment of diabetes.发现可改善糖尿病治疗的基因生物标志物。
Pharmacogenomics. 2009 Aug;10(8):1217. doi: 10.2217/pgs.09.98.
2
[Antidiabetic agents and renal insufficiency].[抗糖尿病药物与肾功能不全]
Nefrologia. 2002;22(4):325-8.
3
[Thiazolidenediones, diabetes and adipogenesis].[噻唑烷二酮类、糖尿病与脂肪生成]
Med Clin (Barc). 1999 Apr 10;112(12):457-8.
4
[The role of combined therapy by insulin and hypoglycemic drugs in diabetes].[胰岛素与降糖药物联合治疗在糖尿病中的作用]
Harefuah. 1993 Mar 1;124(5):281-5.
5
Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.发现具有口服活性、强效且选择性的基于苯并三唑的蛋白酪氨酸磷酸酶1B（PTP1B）抑制剂。
ChemMedChem. 2011 Jun 6;6(6):1011-6. doi: 10.1002/cmdc.201100077. Epub 2011 Apr 19.
6
Oral hypoglycemic agents and the mechanism of diabetes mellitus.口服降糖药与糖尿病发病机制
N Engl J Med. 1968 Jan 18;278(3):148-55. doi: 10.1056/NEJM196801182780306.
7
Precision diabetes: Where do we stand today?精准糖尿病：我们如今处于什么位置？
Indian J Med Res. 2018 Nov;148(5):472-475. doi: 10.4103/ijmr.IJMR_1628_18.
8
Pharmacotherapy of diabetes mellitus.
Lippincotts Prim Care Pract. 1997 Nov-Dec;1(5):537-49.
9
Clinical use of oral hypoglycemic agents.口服降糖药的临床应用。
Am J Hosp Pharm. 1976 Sep;33(9):943-7.
10
[Sulfonylureas and diabetes mellitus].
Med Clin (Barc). 1983 Sep 17;81(7):302-4.
Zotero 插件